Stockholders Approve Management Proposals, Including New Stock Compensation Plan
EMN sits 34% above its 52-week low of $56.11.
Summary
Eastman Chemical stockholders approved all management proposals at the Annual Meeting, including a new stock compensation plan, while rejecting a shareholder proposal to lower the special meeting threshold.
Key Events · Corporate Governance and Compliance · EMN
-
Management Proposals Approved
Stockholders elected all eleven director nominees, ratified PricewaterhouseCoopers LLP as the independent auditor, and approved executive compensation in an advisory vote.
-
New Stock Compensation Plan Approved
The 2026 Omnibus Stock Compensation Plan was approved, authorizing future equity awards for employees and directors.
-
Shareholder Proposal Rejected
An advisory stockholder proposal to lower the threshold for calling special shareholder meetings to 10% was not adopted.
Analysis · EMN · Industrial Applications And Services
Eastman Chemical's stockholders approved all management-backed proposals at the Annual Meeting, including the election of directors, executive compensation, and a new stock compensation plan. This outcome reinforces current management's control and provides flexibility for future equity compensation, which could lead to dilution. Additionally, a shareholder proposal to lower the threshold for calling special meetings was rejected, reducing potential activist pressure.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1498 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EMN was trading at $74.92 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $8.5B. The 52-week trading range was $56.11 to $84.18. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.